Derivation and validation of a prognostic model for postoperative risk stratification of critically ill patients with faecal peritonitis

Abstract

Background Prognostic scores and models of illness severity are useful both clinically and for research. The aim of this study was to develop two prognostic models for the prediction of long-term (6 months) and 28-day mortality of postoperative critically ill patients with faecal peritonitis (FP).MethodsPatients admitted to intensive care units with faecal peritonitis and recruited to the European GenOSept study were divided into a derivation and a geographical validation subset; patients subsequently recruited to the UK GAinS study were used for temporal validation. Using all 50 clinical and laboratory variables available on day 1 of critical care admission, Cox proportional hazards regression was fitted to select variables for inclusion in two prognostic models, using stepwise selection and nonparametric bootstrapping sampling techniques. Using Area under the receiver operating characteristic curve (AuROC) analysis, the performance of the models was compared to SOFA and APACHE II.ResultsFive variables (age, SOFA score, lowest temperature, highest heart rate, haematocrit) were entered into the prognostic models. The discriminatory performance of the 6-month prognostic model yielded an AuROC 0.81 (95% CI 0.76–0.86), 0.73 (95% CI 0.69–0.78) and 0.76 (95% CI 0.69–0.83) for the derivation, geographic and temporal external validation cohorts, respectively. The 28-day prognostic tool yielded an AuROC 0.82 (95% CI 0.77–0.88), 0.75 (95% CI 0.69–0.80) and 0.79 (95% CI 0.71–0.87) for the same cohorts. These AuROCs appeared consistently superior to those obtained with the SOFA and APACHE II scores alone.ConclusionsThe two prognostic models developed for 6-month and 28-day mortality prediction in critically ill septic patients with FP, in the postoperative phase, enhanced the day one SOFA score’s predictive utility by adding a few key variables: age, lowest recorded temperature, highest recorded heart rate and haematocrit. External validation of their predictive capability in larger cohorts is needed, before introduction of the proposed scores into clinical practice to inform decision making and the design of clinical trials.Electronic supplementary materialThe online version of this article (doi:10.1186/s13613-017-0314-1) contains supplementary material, which is available to authorized users.

Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience

“…Three genome centres (in Bonn, Paris and Oxford) supported the project. A total of 2257 evaluable patients were recruited between May 2006 and December 2008, providing important insights into the epidemiology and genetics of sepsis in Europe [10–16]. Collaborative analytical work continues using the samples which are stored in biobank facilities at the Wellcome Trust Centre for Human Genetics in Oxford.…”

Sepsis 3 and the burns patient: do we need Sepsis 3.1?

“…As mortality from sepsis increases with worsening severity and increasing number of organ dysfunctions, capturing the number of organs involved, the degree of sepsis induced dysfunction and the response to treatment, for all relevant systems, becomes vital in early detection of sepsis and assessment of outcome. 24,[36][37][38][39][40] To that effect, it could be argued that an adaptation of the SOFA score, to include a severity grading of skin dysfunction, may be desirable for the burns population.…”

Evaluating the Possibility of Translating Technological Advances in Non-Invasive Continuous Lactate Monitoring into Critical Care

“…The need for repeated measurement of blood lactate across the broad spectrum of critical conditions, coupled with the increased workload involved in repeated sampling and also the potential for iatrogenic anaemia in critical care patients [ 37 , 38 ], warrants the introduction of non-invasive technology for continuous lactate monitoring.…”